1 documents found
Information × Registration Number 0309U003822, 0106U003512 , R & D reports Title A Muiticenter, Randomized, Double-Blind Placebo-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer. popup.stage_title Дослідження ефективності та систематизація інформації щодо ефективності Дарбопоетину Альфа при лікуванні анемії ракового захворювання. Head Hotko Evgen Stepanovych, Registration Date 30-09-2009 Organization Uzhgorod National University popup.description2 According to results of anemia progression and relaplse analysis patients who received research agent had better chemo-tolerance and time to progression was much longer. These results were evaluated by comparing treatment response and time to death. Toxic symptoms were rare in patients who received research agent. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
A Muiticenter, Randomized, Double-Blind Placebo-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer.
Head: Hotko Evgen Stepanovych. A Muiticenter, Randomized, Double-Blind Placebo-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer.. (popup.stage: Дослідження ефективності та систематизація інформації щодо ефективності Дарбопоетину Альфа при лікуванні анемії ракового захворювання.). Uzhgorod National University. № 0309U003822
1 documents found

Updated: 2026-03-20


Роздрукувати цю сторінку